Are you Dr. Reines?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 11 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
11 W Bridlewood Dr
New Hope, PA 18938Phone+1 215-850-6895Fax+1 215-862-3282
Summary
- Dr. Scott Reines, MD is a board certified psychiatrist in New Hope, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Psychiatry, 1976 - 1979
Albert Einstein College of MedicineClass of 1976
Certifications & Licensure
PA State Medical License 1979 - 2024- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects Start of enrollment: 2015 Dec 01
- A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 575 citationsThe Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controll...Paul J. Hesketh, Steven M. Grunberg, Richard J. Gralla, D. G. Warr, Fausto Roila
Journal of Clinical Oncology. 2003-11-15 - 308 citationsA randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.Leon J. Thal, Steven H. Ferris, Louis Kirby, G. Block, Christopher R. Lines
Neuropsychopharmacology. 2005-06-01 - 791 citationsDistinct Mechanism for Antidepressant Activity by Blockade of Central Substance P ReceptorsMark S. Kramer, N.R. Cutler, John P. Feighner, Ram K. Shrivastava, John Carman
Science. 1998-09-11
Press Mentions
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative PainMay 21st, 2018
Memory Drug Enters Clinical Trial, May Help Treat Cognitive DisordersDecember 30th, 2015
